Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Denise A Yardley, MD
SCRI Development Innovations, LLC
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Northeast Alabama Regional Medical Center
Anniston, Alabama, United States
- Florida Cancer Specialists
Fort Myers, Florida, United States
- Integrated Community Oncology Network
Jacksonville, Florida, United States
- Watson Clinic Center for Cancer Care and Research
Lakeland, Florida, United States
- Northeast Georgia Medical Center
Gainesville, Georgia, United States
- Hematology Oncology Life Center
Alexandria, Louisiana, United States
- Grand Rapids Clinical Oncology Program
Grand Rapids, Michigan, United States
- Spartanburg Regional Medical Center
Spartanburg, South Carolina, United States
- Associates in Hematology Oncology
Chattanooga, Tennessee, United States
- Tennessee Oncology
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2006
- Primary completion
- 29 Feb 2008
- Completion
- 30 Nov 2010
- Last update posted
- 9 Aug 2013
- Registered enrollment
- 32
- Registry id
- NCT00284180
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.